Background-Genome-wide association studies in European Americans have reported several single-nucleotide polymorphisms (SNPs) in the lipoprotein lipase gene associated with plasma levels of high-density lipoprotein cholesterol (HDL-C) and triglycerides. However, the influences of the lipoprotein lipase SNPs on longitudinal changes of these lipids have not been systematically examined. Methods and Results-On the basis of data from 2045 African Americans and 2116 European Americans in the Coronary Artery Risk Development in Young Adults study, we investigated cross-sectional and longitudinal associations of lipids with 8 lipoprotein lipase SNPs, including the 2 that have been reported in genome-wide association studies. Plasma levels of HDL-C and triglycerides were measured at 7 examinations during 20 years of follow-up. In European Americans, rs328 (Ser447Stop), rs326, and rs13702 were significantly associated with cross-sectional interindividual variations in triglycerides and HDL-C (PϽ0.005) and with their longitudinal changes over time (PϽ0.05). The minor alleles in rs326, rs328, and rs13702 that predispose an individual to lower triglycerides and higher HDL-C levels at young adulthood further slow down the trajectory increase in triglycerides and decrease in HDL-C during 20 years of follow-up. In African Americans, these 3 SNPs were significantly associated with triglycerides, but only rs326 and rs13702 were associated with HDL-C (PϽ0.008). Rs328 showed a stronger association in European Americans than in African Americans, and adjustment for it did not remove all of the associations for the other SNPs. Longitudinal changes in either trait did not differ significantly by SNP genotypes in African Americans. Conclusions-Our data suggest that aging interacts with LPL gene variants to influence the longitudinal lipid variations, and there is population-related heterogeneity in the longitudinal associations. (Circ Cardiovasc Genet. 2010;3:179-186.)
L ipoprotein lipase (LPL), associated with the luminal endothelial surface of arteries and capillaries of peripheral tissues, 1 is a key enzyme in the metabolism of lipoproteins. It hydrolyzes plasma lipoprotein triglycerides into free fatty acids and glycerol, converts very-low-density lipoprotein to lowdensity lipoprotein, 1,2 and enhances lipoprotein-receptor interactions. 3 Because the hydrolysis of triglyceride-rich lipoproteins and production of very-low-density lipoprotein contribute to high-density lipoprotein cholesterol (HDL-C) metabolism, LPL activity also plays a role in the regulation of HDL-C levels. 1 Plasma LPL activity and mass are associated with triglycerides and HDL-C in the population at large. 4, 5 
Clinical Perspective on p 186
Several functional polymorphisms in the LPL gene have been studied with regard to their association with lipid profile and risk of coronary heart disease. 6 Among them, the LPL Ser447Stop variant (rs328) is most common, with a frequency of 5.6% to 21.1% in various populations. 6 It involves a C-to-G transversion, which converts the serine 447 codon to a premature termination codon, shortening the LPL molecule at the C-terminal. In a meta-analysis, the LPL Ser447Stop variant was consistently associated with baseline triglyceride and HDL-C levels and predicted risk of coronary heart disease. 6 Furthermore, additional variants in the LPL gene have been identified in recently published whole genomewide association studies. [7] [8] [9] [10] Because triglycerides and HDL-C change with age, 11 it is important to investigate whether the genetic polymorphisms also influence the longitudinal changes in triglycerides and HDL-C within the same individuals. Understanding the evolution of these blood lipids over time can enhance information used in risk prediction and intervention for coronary heart disease. Evidence from 2 previous studies suggests differential influence of the LPL Ser447Stop genotype on the longitudinal patterns of triglycerides and HDL-C. 12, 13 Most of the participants in these 2 studies were European Americans, and only 1 LPL variant was examined. In this study, we investigated the associations of 8 LPL single-nucleotide polymorphisms (SNPs) and their haplotypes, including the Ser447Stop variant, with longitudinal trends of triglycerides and HDL-C in a large cohort from the Coronary Artery Risk Development in Young Adults (CARDIA) study, including both African Americans and European Americans and spanning 20 years and 7 examinations. The cohort was recruited mostly by telephone; through random sampling from populations in Birmingham, Ala, Chicago, Ill, and Minneapolis, Minn; and through membership of a large prepaid health plan in Oakland, Calif. Approximately equal numbers of blacks and whites; men and women; persons aged 18 to 24 years and 25 to 30 years; and persons with a high school education, higher education, or less than high school education were recruited at each site. This study was approved by the institutional review board at the participating universities, and all participants gave informed consent.
Methods Participants
A
Clinical Measurements
Information on clinical measurements, including demographic characteristics, lifestyle habits, anthropometric variables, physical activity, and medical history, are provided in the online-only Data Supplement. Demographic and lifestyle characteristics also are presented in Table 1 . Blood samples were drawn after an overnight fast. Plasma was stored at Ϫ70°C. Triglycerides were measured enzymatically within 6 weeks of collection. 14 HDL-C was determined after precipitation with dextran sulfate/magnesium chloride of lipoproteins containing low-density lipoprotein cholesterol. 15 Comparability of the lipid assays was scrupulously assessed across the examinations.
Genotyping
Genotyping of rs328 was performed with a TaqMan assay on the participants who attended the year 10 examination, and valid results were obtained in 3817 participants. Genotype data for the following 7 LPL SNPs were obtained for participants who were examined at years 15 (94%) or 20 (6%), depending on sample availability: rs34309063, rs13266204, rs10104051, rs248, rs326, rs13702, and rs9644636. Genotyping for these SNPs was performed as part of the Modeling DNA Diversity in Reverse Cholesterol Transport study, an ancillary study to CARDIA. The 7 SNPs also were genotyped using the TaqMan method. Valid results for these SNPs were obtained from 4039 participants. This study included 4162 participants who had triglyceride and HDL-C measurements from at least 2 examinations and genotype data for at least 1 of the 8 LPL SNPs.
Statistical Analysis
The distributions of HDL-C and triglycerides were evaluated by skewness and kurtosis statistics and visualization of histogram. A skewness or kurtosis of Ͼ1.5 was considered a departure from the normal distribution. Triglyceride values were log-transformed naturally to normalize their distributions, and the transformed values were used in all statistical tests. During quality-control analysis, we found that plasma cholesterol measurements were systematically elevated at year 2; thus, HDL-C levels at year 2 were multiplied by 0.9681 before analysis as recommended by the CARDIA Quality Control Committee.
All genetic analyses were conducted in European Americans and African Americans separately. The 2 goodness-of-fit test was used to evaluate the Hardy-Weinberg equilibrium. Among the 8 SNPs, rs34309063, rs13266204, rs248, rs328, and rs9644636 had Ͻ30 counts of homozygosity for the minor allele in 1 or both race groups. For these SNPs, participants with minor allele homozygosity and heterozygosity were pooled into 1 group in the genetic association analysis. Genotypes for the other 3 SNPs were analyzed as 0, 1, or 2 copies of the minor allele in an additive genetic model. ANOVA implemented in the PROC GLM procedure of SAS was used to assess the associations of the LPL SNPs with triglycerides and HDL-C at each examination and with changes in triglycerides and HDL-C between baseline and follow-up examinations. Both types of analyses were adjusted for age, sex, and field center. To reduce the extent of multiple testing, the analysis of lipid changes was conducted only for examination at years 10, 15, and 20 and for SNPs that showed significant associations in the overall association analysis as discussed later.
To investigate the overall associations of the LPL SNPs with the lipids across the 7 examinations, lipid measurements from these examinations were analyzed simultaneously using repeated measures regression analysis (SAS PROC MIXED), adjusting for age, examination year, sex, and field center. The analysis accounts for within-person correlation between examinations by assuming compound symmetry, that is, a constant correlation for these lipid fractions between pairs of examinations.
For SNPs that showed significant associations in the overall association analysis, mean levels of the lipids at each examination by genotype group were calculated in PROC MIXED models after adjusting for baseline age, sex, and field center. The adjusted means were used to plot the longitudinal pattern of the lipids by genotype (Figure and supplemental Figure I ). When a linear trend was evident, tests of interaction between genotype and follow-up time as a continuous variable were conducted in PROC MIXED models that adjusted for baseline age, sex, and field center. The testing for interactions of SNP by follow-up time was used as a proxy for the testing for SNP-by-age interactions because follow-up time provides more information than longitudinal age for these types of data (see Discussion section for details).
Assessment of Linkage Disequilibrium and Haplotype Analysis
The genetic analysis program Haploview 16 Data are presented as meansϮSD unless otherwise indicated.
significant SNPs from the single-SNP analysis. Haplotypes were inferred by using PHASE version 2.1.1. 17, 18 (Refer to the Data Supplement for details about the probability distribution of haplotypes.) For each individual, the most likely haplotype pairs were used. The overall associations of the lipid variables with haplotypes across the 7 examinations were assessed in the mixed analysis models in which the probability assignment for corresponding haplotype pairs was used as a weight in the analysis. Haplotypes with a frequency Ͼ5% were simultaneously analyzed in the same model. More rare haplotypes with a frequency Յ5% were pooled. Haplotype analysis of longitudinal change in triglycerides and HDL-C at year 20, which does not involve correlated observations, was conducted by using a generalized linear regression model implemented in the program haplo.stats for R 19, 20 in which haplotype ambiguity was taken into account.
Multivariable Adjustment
In the previously mentioned single-SNP and haplotype analyses of longitudinal changes, a multivariable adjustment was performed by additionally adjusting for body mass index (at baseline and change from baseline), smoking status (at baseline and current examination), alcohol consumption (mL/day at baseline and change from baseline), and physical activity score (at baseline and change from baseline). Because rs328 is the only known functional SNP among the 8 SNPs, we also adjusted for rs328 in the analyses of other SNPs that showed significant associations to evaluate whether the associations for the other SNPs were driven by LD with rs328.
Sensitivity Analyses
In a subset of 1622 African Americans for whom the percentage of African ancestry was estimated, 21 we repeated the analyses for significant genetic associations with an additional adjustment for the percentage of African ancestry. We also repeated the analyses of longitudinal lipid changes, including the test of interactions between follow-up time and SNPs, after excluding the participants who were on lipid-lowering medications (nϭ338) or lost to follow-up (nϭ1646). (Refer to the Data Supplement for details.)
Results Table 1 presents demographic and lifestyle characteristics at baseline in African Americans and European Americans. Table 2 presents mean levels of triglycerides and HDL-C by examination and race. Pooling all 7 examinations yielded 29 134 possible records for both triglycerides and HDL-C. Table 3 presents information on the 8 LPL SNPs stratified by race. Genotype distributions for all 8 agreed with the Hardy-Weinberg equilibrium in both African Americans and European Americans (PϾ0.05). Based on pairwise DЈ measurement, the last 4 SNPs (rs326, rs328, rs13702, rs9644636) formed a distinct haplotype block in both groups (supplemental Figure II) . Among the SNPs, the magnitude of correlations (r 2 ) was low, except SNPs rs34309063 with rs13266304 and rs326 with rs13702 were at least moderately correlated (r 2 Ͼ0.50) (supplemental Figure III) . The correlations in European Americans were higher than in African Americans.
P values for the association tests between each of the 8 LPL SNPs and the 2 lipids at each examination are summarized in the supplemental Table I . In both groups, rs326 and rs13702 were consistently associated with triglycerides and HDL-C across the 7 examinations (PϽ0.05). In contrast, rs328 was consistently associated with triglycerides in both groups and with HDL-C in the European Americans only. Table 4 presents overall associations of the LPL SNPs with triglycerides and HDL-C in the pooled analysis of the data from the 7 examinations by using mixed analysis models. Consistent with the overall pattern of associations across individual examinations, rs326, rs328, and rs13702 were significantly associated with triglycerides in both groups and with HDL-C in European Americans; the G, G, and C alleles in rs326, rs328, and rs13702, respectively, were associated with lower levels of triglycerides and higher levels of HDL-C. In African Americans, the G and C alleles of rs326 and rs13702 showed significant and positive associations with HDL-C. The association between rs328 and HDL-C in African Americans was in the same direction as that in European Americans, but the magnitude of the association was weaker and did not reach statistical significance (Pϭ0.21). We repeated the analysis for rs326 and rs13702 after additionally adjusting for rs328, the variant encoding for the 447 stop codon in LPL. The additional adjustment modestly attenuated, but did not abolish, the associations of rs326 and rs13702 with triglycerides or HDL-C in European Americans (Table 4) . In African Americans, the additional adjustment reduced the associations between both SNPs and triglycerides to below statistical significance but did not result in noticeable changes in the associations for HDL-C. Tables 5 and 6 present mean changes in log-transformed triglycerides and HDL-C from baseline to years 10, 15, and 20 by genotypes for rs326, rs328, and rs13702 after adjustment for baseline age, sex, and field center. In African Americans, the changes in log-transformed triglycerides (Table 5) and HDL-C (Table 6 ) from baseline to the 3 follow-up examinations did not significantly differ across genotype groups (PϾ0.05). In European Americans, there was a trend toward less increase in triglycerides from baseline to each of the 3 latter examinations associated with the G, G, and C alleles in rs326, rs328, and rs13702 compared with the reference homozygosity groups. This genotype-related difference reached statistical significance at all of the 3 examinations for rs326, at the year 20 examination for rs328, and the year 10 and 20 examinations for rs13702. Moreover, the genotype-related gap became mostly widened at the year 20 examination and was only slightly attenuated in the multivariable adjustment (Table 5 ). For HDL-C in European Americans (Table 6 ), the G, G, and C alleles in rs326, rs328, and rs13702 tended to be associated with smaller reductions in HDL-C at years 10 and 15 and with larger increases at year 20 compared with the reference homozygous groups. These effects were statistically significant at year 20 for all 3 SNPs. The associations at year 20 were not attenuated for rs326 and rs13702 after multivariable adjustment. To evaluate whether the previously observed longitudinal changes associated with rs326 Table 4 . †Reference group in the association results based on an additive model presented in Table 4 . For illustrative purposes, the longitudinal patterns of logtransformed triglycerides and HDL-C by rs13702 and rs328 genotypes are presented in the Figure for European Americans and supplemental Figure I for African Americans. For the interactions of longitudinal time with genotype in European Americans, at the baseline examination, CC homozygotes for rs13702 had an average of 8.0 mg/dL lower triglycerides and 1.9 mg/dL higher HDL-C than TT homozygotes; this gap was widened to 21.2 mg/dL for triglycerides and 4.2 mg/dL for HDL-C 20 years later. Because the log-transformed triglycerides across the 7 examinations exhibited a linear trend, we tested the interactions between the 3 SNPs and follow-up time (as a continuous variable) on log-transformed triglycerides using mixed-analysis models. Consistent with the tests of lipid changes at individual follow-up examinations, there was a significant interaction between each of the 3 SNPs and follow-up time in European Americans independent of the influence of baseline age, sex, field center, body mass index, smoking status, alcohol consumption, and physical activity (Table 5 ). In African Americans, there was no significant interaction between the 3 SNPs and follow-up time (data not shown).
Haplotype Analysis
Haplotype analysis was performed for haplotypes inferred based on rs326, rs328, rs13702, and rs9644636. Four and 5 haplotypes with frequency Ͼ5% were reconstructed for European Americans and African Americans, respectively (supplemental Table II ).
Cross-Sectional Associations
In both race groups, 2 haplotypes (GGCT and GCCT) were significantly associated with triglycerides and HDL-C in the pooled analysis using mixed-analysis models (supplemental Table II ). For triglycerides, GGCT had a stronger effect than GCCT in both race groups; for HDL-C, GGCT had a stronger effect in European Americans, whereas its effect was not ‡Additionally adjusted for body mass index (at baseline and change from baseline), smoking status (at baseline and current examination), alcohol consumption (mL/day at baseline and change from baseline), and physical activity score (at baseline and change from baseline).
§Interactions between the SNPs and follow-up time (years 0, 2, 5, 7, 10, 15, and 20) as a continuous variable. substantially different from GCCT in African Americans. This race-related difference in haplotype association was likely due to different effect of rs328 between the 2 groups.
Longitudinal Changes at Year 20 Compared With Baseline
In European Americans, only GGCT was significantly associated with changes in triglycerides and HDL-C (supplemental Table III) . One copy of this haplotype was associated with a 0.08Ϯ0.03 mg/dL (Pϭ0.007) smaller increase in triglycerides and a 1.35Ϯ0.67 mg/dL (Pϭ0.0457) greater increase in HDL-C than the common haplotype ACTT. Similar results were observed in the multivariate adjustment models (data not shown). There was no significant haplotype association in African Americans. In both race groups, additional adjustment for the 4 SNPs that were used to reconstruct the haplotypes abolished all the haplotype associations in both cross-sectional and longitudinal analyses (data not shown), indicating that the haplotype analysis did not contribute additional information beyond the single-SNP approach.
Sensitivity Analyses
In African Americans, additional adjustment for the percentage of African ancestry did not materially change the significant associations reported in Table 4 (data not shown). Additionally, excluding participants who were on lipidlowering medications or lost to follow-up did not result in material changes in the associations between SNPs and longitudinal lipid changes (data not shown).
Discussion
The present study is based on the large cohort of the CARDIA study that has data collected from 7 examinations during 20 years of follow-up. In European Americans, the SNPs rs328 (Ser447Stop), rs326, and rs13702 were significantly associated with cross-sectional variations in triglycerides and HDL-C as well as with longitudinal changes in the 2 traits during 20 years of life span (PϽ0.05). In African Americans, these 3 SNPs were significantly associated with interindividual variation in triglycerides, but only rs326 and rs13702 were associated with HDL-C (PϽ0.008). The SNP rs328 was not the statistical variable explaining most of the observed associations and showed a stronger association in European Americans than in African Americans. The associations observed in African Americans did not change significantly over time.
A meta-analysis of previous candidate gene studies of LPL functional variants reported 3 variants that showed consistent associations with triglycerides and HDL-C. 6 Of the 3 significant variants, only rs328 has a minor allele frequency of Ͼ5%. More recently, common SNPs in the LPL gene have been reported in several genome-wide association studies of lipid profile, which have been performed predominantly in populations of European ancestry. [7] [8] [9] [10] From these studies, 4 common SNPs from the LPL gene were associated with triglycerides at the genome-wide significance level: rs328, rs2197089, rs325, and rs326. [7] [8] [9] [10] For HDL-C, 3 common SNPs were identified: rs328, rs2197089, and rs326. 7, 8, 10 Because not all the reported SNPs are in high LD, these multiple variants indicate the possibility of multiple independent signals from the LPL gene. Our study, which included 2 of the reported SNPs from the genome-wide association studies, contributes to this body of literature by showing that the associations of blood lipids with rs328 do not completely explain the observed associations for rs326 and rs13702 in European Americans.
Because the majority of candidate gene studies of LPL variants and the genome-wide association studies of lipids were based on participants of European ancestry, it remains to be determined whether the variants identified in European populations have similar effects in African Americans. To the best of our knowledge, our study is 1 of the only 2 studies that has specifically evaluated multiple LPL SNPs with regard to their association to triglycerides and HDL-C in African American populations. Deo et al 22 successfully genotyped 85 of 95 tagging SNPs in the LPL gene and adjacent segment in 3300 unrelated African Americans from the Jackson Heart Study. In all participants, rs10096633, rs328, and 4 other SNPs that correlated with rs328 at r 2 ϭ1 in participants with European ancestral background were significantly associated with triglycerides. The SNP rs328 exhibited a significant interaction with local ancestry, with a smaller effect size in those with 2 copies of African ancestral chromosomes compared with those with at least 1 copy of European ancestral chromosome. Because LD extends in general over longer stretches in Europeans than in Africans, Deo et al concluded that rs328 had, at most, a modest effect on triglycerides, and the stronger effect associated with rs328 in European popu- ‡Additionally adjusted for body mass index (at baseline and change from baseline), smoking status (at baseline and current examination), alcohol consumption (mL/day at baseline and change from baseline), and physical activity score (at baseline and change from baseline).
lations is due to other causal variants that are in LD with rs328. 22 This is in line with our findings that the effect sizes associated with rs328, rs326, and rs13702 were stronger in European Americans than in African Americans and that adjusting for rs328 abolished the associations for rs326 and rs13702 in African Americans but not in European Americans. In our study, the effects carried by rs326 and rs13702 in European Americans are mediated by rs328 and additional causal variants, whereas those in African Americans are likely attributable to rs328. For HDL-C in Deo et al, only rs13702 showed a significant association, which is essentially in agreement with our findings that rs13702 and the haplotype carrying the at-risk allele for rs13702 showed a stronger (and significant) effect than rs328. Future studies are need to determine whether it is rs13702 itself or other variants in LD with rs13702 that influence HDL-C levels.
Furthermore, our study shows that the LPL variants that have been confirmed to contribute to the cross-sectional interindividual differences in triglycerides and HDL-C also influence longitudinal changes in the same individuals among European Americans. The minor alleles in rs326, rs328, and rs13702 that predispose an individual to lower triglycerides and higher HDL-C levels at young adulthood further slow down the trajectory increase in triglycerides and decrease in HDL-C or promote the increase in HDL-C during 20 years of follow-up. The genotype-related longitudinal effects became strongest at year 20 when participants were aging into middle-aged adulthood. Two previous studies, both focusing on rs328 only, have investigated the longitudinal effects of the LPL gene polymorphism on triglycerides and HDL-C. 12, 13 In the first study, Chen et al 12 measured triglycerides and HDL-C in 597 white and 232 black children aged 5 to 18 years at baseline and then again after 14.6 to 20.3 years of follow-up. They found that rs328 was not associated with triglycerides or HDL-C in childhood but showed a significant association with both in adulthood, implying an SNP by longitudinal time interaction. The second study by Webster et al 13 was conducted in 2864 adults of European ancestry for whom lipids were measured at 4 to 6 time points during 15.9 to 17.2 years of follow-up. A significant SNP-by-age interaction was detected for HDL-C but not for triglycerides, and the minor allele at rs328 was associated with an increase in HDL-C with increasing age. In our study, we did not model SNP-by-age interactions. Instead, we analyzed the associations of longitudinal change with SNP genotypes and SNPby-time interactions. We chose to use this slightly different approach based on the consideration that participants entered into the study at different ages and were not followed up annually; therefore, each participant only contributed data to certain age groups, and the sample size for each individual age group was more limited than that for each follow-up time point. Nevertheless, the longitudinal time effects mostly reflect the age effects, and findings from our study in general agree with the 2 studies and extend beyond them by including large European American and African American populations, multiple SNPs from the LPL gene, and more follow-up examinations.
Because the most uniform and evident change in participants' characteristics during the follow-up is increase in age, the most plausible interpretation for the longitudinal effects of the LPL SNPs is differential expression of the LPL variants with aging, especially after participants became middle-aged. In animal studies, a substantial reduction in LPL activity has been observed with aging in adipose tissue, heart, and postural skeletal muscles. 23, 24 In humans, postheparin plasma LPL activity was reduced in elderly compared with younger adults. 25 Therefore, it is plausible to postulate that the longitudinal influence of the LPL SNPs may reflect protective effects of responsible variants against the decline of LPL activity with aging. Another explanation is that the distributions in other risk factors may change over time and interact with the LPL variants. In our study, the associations between the LPL SNPs and the lipid changes were only slightly attenuated after adjusting for body mass index, physical activity, smoking, and alcohol consumption. Dietary change, which might contribute to the longitudinal changes in triglycerides and HDL-C, was not included in the study because dietary measurements were collected at baseline and the year 7 and 20 examinations and because there was a significant number of participants (300 to 400) who were missing for dietary data.
The associations between the LPL SNPs and longitudinal change of triglycerides and HDL-C were detected in European Americans but not in African Americans in this study. One explanation for these discrepant findings may be that the longitudinal associations observed in European Americans likely reflect additional effects from other causal variants in LD with the observed SNPs. The signals from those underlying causal variants were not captured in African Americans because of a shorter LD distance in African Americans. A second explanation may be that other genetic or environmental factors that interact with the LPL variants to influence the longitudinal patterns distributed differently between the 2 populations.
The characteristics of the mutant allele homozygotes for rs328 (Ser447Stop) are of interest because this is the only functional variant among the 8 SNPs and has been extensively investigated in the literature. Baseline mean and longitudinal changes in triglycerides and HDL-C by rs328 genotype are presented in supplemental Table IV. For the cross-sectional and longitudinal associations that were statistically significant (Tables 4 through 6 ), the mutant allele homozygotes (GG) tend to have a stronger effect in lowering triglycerides and increasing HDL-C than the heterozygotes (GC). This variant introduces a premature termination codon that shortens the LPL molecule at the C-terminal. Although the molecular mechanisms underlying the beneficial effect on lipids have not been clearly delineated, data from the literature suggest that this mutation confers a gain-of-function effect that is possibly attributable to increased LPL activity, especially under postprandial conditions. 26
Conclusion
We detected multiple variants in the LPL gene that are associated with interindividual differences in triglycerides and HDL-C in both European Americans and African Americans and with longitudinal changes in the 2 traits in European Americans. Findings from this study not only contribute to the current understanding of genetic influences for lipids, but also provide a basis for future fine-mapping studies to identify additional causal variants contributing to both cross-sectional and longitudinal variations in triglycerides and HDL-C. Identification of such variants will improve risk stratification and pharmaceutical intervention to reduce the risk of coronary heart disease over a long life span.
